Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK-driven lung cancer via concurrent integrin and MET signaling
Preprint in bioRxiv (August 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Preprint in bioRxiv (August 2024)
Article in Frontiers in Immunology (July 2024)
Article in Journal of Oceanology and Limnology (February 2024)